Article
The Safety of Low-Molecular-Weight Heparin Bridging Therapy in Patients Receiving Preoperative Oral Antithrombotic Drugs During Spinal Fusion Surgery
2026-01-12
Abstract excerpt
<title>Abstract</title> <p> <bold>【Purpose】</bold> To evaluate whether preoperative oral antithrombotic drugs increase perioperative bleeding risk in spinal fusion patients receiving low-molecular-weight-heparin (LMWH) bridging therapy, and compare bleeding risk with general patients. <bold>【Methods】</bold> Patients who underwent spinal fusion (2019–2024) at two hospitals were grouped: Oral Anticoagulation go...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 2efe771a-66d3-56e3-9d58-592ce80ac18f
- DOI
- 10.21203/rs.3.rs-8344022/v1
